Novo Nordisk Canada Inc.

Novo Nordisk Canada Inc.

Novo Nordisk is a focused healthcare company. With the broadest
diabetes product portfolio in the industry, including the most
advanced products within the area of insulin delivery systems,
Novo Nordisk is the world leader in diabetes care. In addition,
Novo Nordisk has a leading position within areas such as
coagulation disorders, growth disorders and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical
products and services that make a significant difference to
patients, the medical profession and society.

Company Details

Year Established: 1993

Total Sales ($CDN): $50,000,000 +

Number of Employees: 100

Company Information

Patrick Loustau
Title: President
Telephone: (905) 629-4222
Fax: (905) 629-2698
Email: Click Here

Marie-claire Mcmullin
Title: Executive Assistant
Telephone: (905) 629-6102
Fax: (905) 629-2698
Email: Click Here

Products

Novolin

Niastase
Niastase is recombinant factor VIIa used in the treatment of hemophilia.

Novolin Pen
Novolin Pen is a device for the injection of insulin from prefilled cartridges allowing patients greater convenience and improved quality of life.

Novorapid
A clear solution containing a modified form of human insulin, is also known as a 'rapid-acting insulin analogue'.

Gluconorm
Repaglinide Tablet

Induo
Combined insulin doser and blood glucose monitor

Innovo
Insulin doser with built in memory

Flexpen
A prefilled insulin pen

Novofine Needles
Needles for Novo Nordisk insulin injection devices

Novopen Junior
Pen with half-unit dose increments to fine-tune small doses for children.

Vagifem
Used for Local Oestrogen treatment

Services

Biotechnology